Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s):  LBLTF

Healthcare Biotechnology
Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post... see more

Recent & Breaking News (TSXV:LBL.H)

Lattice Biologics (V.LBL) adds biotech opportunity to Stockhouse’s Deal Room

Gaalen Engen April 22, 2016

Lattice Biologics Preparing to Launch Three New Products Featuring Matrix-Assisted Regeneration (MAR) Technology

Marketwired April 18, 2016

Lattice Biologics Offering Exclusive Access to Revolutionary High-Throughput Precision Chemotherapy Screening for Breast Cancer

Marketwired April 15, 2016

Lattice Biologics Closes 60% of Private Placement Announced on March 18, 2016

Marketwired April 1, 2016

Lattice Biologics and Sunnybrook Research Institute Commence Study to Develop New Cancer Screening Methods

Marketwired March 30, 2016

Lattice Biologics Announces New Private Placement

Marketwired March 18, 2016

IIROC Trading Resumption - LBL

Canada NewsWire March 2, 2016

IIROC Trade Resumption - Lattice Biologics Ltd.

Newsfile March 2, 2016

Lattice Biologics Announces Conversion of US$1.4 Million in Debt to Equity

Marketwired March 2, 2016

IIROC Trading Halt - LBL

Canada NewsWire March 2, 2016

IIROC Trade Halt - Lattice Biologics Ltd.

Newsfile March 2, 2016

Lattice Biologics First Quarter 2016 Highlights

Marketwired March 1, 2016

Lattice Biologics Announces Grant of Stock Options

Marketwired February 22, 2016

Lattice Biologics (V.LBL) building on biotech success one block at a time

Gaalen Engen February 9, 2016

Lattice Biologics (V.LBL) appoints new board and announces debt conversion

Stockhouse Editorial January 5, 2016

Lattice Biologics Continues Progress After Its RTO Announcement

Marketwired January 5, 2016

Lattice Biologics Completes Merger with Blackstone Ventures

Stockhouse.com December 31, 2015

Lattice Biologics / Blackstone Ventures Merger Update

Marketwired October 16, 2015

Blackstone to Acquire Lattice Biologics

Marketwired August 6, 2015

IIROC Trading Halt - BLV

Canada NewsWire August 4, 2015